Skip to main content

Retrieve Medical Announces Issuance of Second Patent in “Creating and Updating Problem Lists for Electronic Health Records” Patent Family

Written by Customer Service on . Posted in Public Companies.

BEDMINSTER, N.J., April 10, 2025 (GLOBE NEWSWIRE) — Retrieve Medical Holdings, Inc. (OTC Pink: RMHI), today announced the issuance of a second U.S. patent in its growing patent family titled “Creating and Updating Problem Lists for Electronic Health Records.” This newly granted patent, U.S. Patent No. 12,272,437 B2, was issued by the United States Patent and Trademark Office on April 8, 2025, to inventors Thomas III et al. It further expands Retrieve Medical’s intellectual property portfolio in the area of advanced problem list management technologies for Electronic Health Record (EHR) systems.

Strengthening the Future of EHR Problem List Management
Problem lists are critical documents that outline a patient’s active and past health conditions, including illnesses, injuries, and chronic diseases. An accurate and up-to-date problem list enables clinicians to deliver better care, avoid medical errors, and make informed decisions. However, traditional EHR systems often lack the flexibility, accuracy, and real-time updating needed to keep problem lists truly reliable.

Key Advancements Introduced in the Second Patent

  • Real-Time Synchronization: The system uses natural language processing (NLP) to detect updates in clinical documentation and apply them instantly across the relevant problem lists, minimizing manual data entry and reducing errors.
  • Duplicate Entry Prevention: NLP algorithms identify and eliminate redundant entries across the problem list hierarchy, ensuring data integrity.
  • Role-Based Access Control: Healthcare providers are granted access permissions dynamically based on their role and scope of practice, protecting data privacy while enhancing usability.
  • Optimized Data Transmission: The system transforms annotated data into streamlined keyword formats for efficient transmission, even during high-traffic network usage.

A Growing Foundation for Innovation in Healthcare IT
“Our goal has always been to empower healthcare professionals with tools that reduce administrative burden and enhance clinical accuracy,” said Jerry Swon, CEO at Retrieve Medical. “This second patent underscores our commitment to delivering smarter, safer, and more efficient solutions for the modern healthcare ecosystem.”

About Retrieve Medical Holdings Inc.
Retrieve Medical Holdings, Inc. is transforming healthcare with its cutting-edge software platform, Retrieve DxTM. Using advanced natural language processing, Retrieve Dx analyzes patient data from multiple sources, helping physicians quickly understand complex clinical histories and diagnose chronic conditions. This technology integrates with leading electronic medical record systems such as Epic and Oracle Cerner, improving workflow, boosting patient outcomes, and increasing revenue for healthcare providers.

For more information, visit Retrieve Medical, Inc. at www.retrievemedical.com.

Contact info: Harriet Donnelly, CMO
Retrieve Medical, Inc.
hdonnelly@retrievemedical.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.